Lipid Profile and Management of Dyslipidemias in Pregnancy

Dyslipidemia is a significant risk factor for atherosclerotic cardiovascular disease (ASCVD). Abnormal maternal lipid profiles in pregnancy are associated with pregnancy complications including preeclampsia, gestational diabetes, and pre-term delivery as well as increased ASCVD risk for both mother and child. Dyslipidemia management remains a central tenet for atherosclerotic cardiovascular disease prevention for women who are thinking about becoming pregnant or are already pregnant. Effective individualized guidance and multidisciplinary lifestyle/dietary strategies, along with targeted pharmacological interventions, are required for the successful management of lipid disorders in pregnancy in order to optimize outcomes. This review discusses the physiological changes occurring in lipid metabolism during pregnancy and provides an overview of the current strategies for managing dyslipidemia during pregnancy, with a special focus on consideration of pharmacological therapy.

Authors

Institutions

Publication Details

Journal
Journal of Cardiovascular Development and Disease
Published
2025-11-16
DOI
https://doi.org/10.3390/jcdd12110445
Primary Topic
Pregnancy and preeclampsia studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Lipid Profile and Management of Dyslipidemias in Pregnancy

Constantine E. Kosmas, Christina Kostara, Lοukianos S. Rallidis, Ioannis Hoursalas et al.
Journal of Cardiovascular Development and Disease
Pregnancy and preeclampsia studies
article

Lipid Profile and Management of Dyslipidemias in Pregnancy

Constantine E. Kosmas, Christina Kostara, Lοukianos S. Rallidis, Ioannis Hoursalas, Eleni-Angeliki Zoumi
article en

Abstract

Dyslipidemia is a significant risk factor for atherosclerotic cardiovascular disease (ASCVD). Abnormal maternal lipid profiles in pregnancy are associated with pregnancy complications including preeclampsia, gestational diabetes, and pre-term delivery as well as increased ASCVD risk for both mother and child. Dyslipidemia management remains a central tenet for atherosclerotic cardiovascular disease prevention for women who are thinking about becoming pregnant or are already pregnant. Effective individualized guidance and multidisciplinary lifestyle/dietary strategies, along with targeted pharmacological interventions, are required for the successful management of lipid disorders in pregnancy in order to optimize outcomes. This review discusses the physiological changes occurring in lipid metabolism during pregnancy and provides an overview of the current strategies for managing dyslipidemia during pregnancy, with a special focus on consideration of pharmacological therapy.

Journal of Cardiovascular Development and DiseaseVol. 12(11)
University of Ioannina (GR), Guy's and St Thomas' NHS Foundation Trust (GB), National and Kapodistrian University of Athens (GR), European University Cyprus (CY)
Openalex Percentile: Top 56%
Pregnancy and preeclampsia studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.